Product Information
GLYCERIN 2 GM SUPPOSITORY is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2171 per EA under NDC 57237032521. Its NADAC has been published 102 times since Oct 23, 2024.
Strength
2 g/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237032521
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
1/21/2026
Active Ingredients
GLYCERINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007.54On Market Since
8/24/2023
Pharmacological Classes
Price Statistics
The NADAC for GLYCERIN 2 GM SUPPOSITORY has been published 102 times since Oct 23, 2024, and over the history we have for it it has declined 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2171 per EA |
|---|---|
| All-time high | $0.2714 (Aug 13, 2025) |
| All-time low | $0.2162 (Jan 22, 2025) |
| 52-week high | $0.2540 |
| 52-week low | $0.2170 |
| Median price | $0.2215 |
| Average price | $0.2304 |
| Largest weekly change | -8.8% (Nov 20, 2024) |
| Weeks tracked | 102 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCERIN 2 GM SUPPOSITORY?
The current National Average Drug Acquisition Cost (NADAC) for GLYCERIN 2 GM SUPPOSITORY, manufactured by Rising Pharma Holdings Inc., is $0.2171 per EA (NDC 57237032521), effective Sep 30, 2026.
How has the price of GLYCERIN 2 GM SUPPOSITORY changed over time?
Over the history we have for it, the NADAC for GLYCERIN 2 GM SUPPOSITORY has declined 10.6%. It has been tracked across 102 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for GLYCERIN 2 GM SUPPOSITORY?
Since Oct 23, 2024, the NADAC for GLYCERIN 2 GM SUPPOSITORY has ranged from a low of $0.2162 (Jan 22, 2025) to a high of $0.2714 (Aug 13, 2025), with a median of $0.2215 per EA.
Are there cheaper alternatives to GLYCERIN 2 GM SUPPOSITORY?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYCERIN ADULT SUPPOSITORY, is $0.1031 per EA — about 53% below GLYCERIN 2 GM SUPPOSITORY.
Who manufactures GLYCERIN 2 GM SUPPOSITORY?
GLYCERIN 2 GM SUPPOSITORY (NDC 57237032521) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.